Oncology & Cancer

Finding new combination therapies for neuroblastoma

A phase 2 clinical trial has found that combining a novel compound called alisertib with chemotherapy has anti-tumor activity in children with high-risk, relapsed neuroblastoma. The New Approaches to Neuroblastoma Therapy ...

page 1 from 2